FibroBiologics

About:

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

Website: https://www.fibrobiologics.com/

Twitter/X: fibrogenesis

Top Investors: The Global Emerging Markets Group

Description:

Based in Houston, Texas, FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells. Currently, FibroBiologics holds 150+ U.S. and International issued patents/patents pending across a variety of clinical pathways, including Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.

Total Funding Amount:

$105M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2021-01-01

Contact Email:

Johrenk7(AT)gmail.com

Founders:

Pete O'Heeron

Number of Employees:

1-10

Last Funding Date:

2023-03-17

IPO Status:

Public

Industries:

© 2025 bioDAO.ai